Appropriate treatment of acute otitis media in the era of antibiotic resistance

Pediatric Drugs

Volumn 12, Issue SUPPL. 1, 2010, Pages 3-9

  Dagan, Ron ^a,b  

^a Soroka University   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME AXETIL; COTRIMOXAZOLE; MACROLIDE; ANTIINFECTIVE AGENT;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CLINICAL ASSESSMENT; DRUG TREATMENT FAILURE; ERADICATION THERAPY; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; BACTERIA; DRUG EFFECTS; METABOLISM; MICROBIOLOGY; OTITIS MEDIA;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; HUMANS; OTITIS MEDIA; TREATMENT OUTCOME;

EID: 77954186249     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11538720-S0-000000000-00002     Document Type: Review

References (32)

1. Pelton SI. New conceptsinthe pathophysiology and managementof middle ear disease in childhood. Drugs 1996;52:62-6
2. Dagan R, Leibovitz E. Bacterial eradication in the treatment of otitis media. Lancet Infect Dis 2002;2:593-604
3. Craig W, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15:255-9
4. Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine, 3rd edn. Baltimore, MD, USA: Williams & Wilkins, 1999:403-31
5. Leibovitz E, Raiz E, Piglansky L, et al. Resistance pattern of middle ear fluid in acute otitis media. Pediatr Infect Dis J 2004;23:1142-55
6. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004;23:829-33
7. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004;23(9):824-8
8. Segal N, Givon Lavi N, Leibovitz E, et al. Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis 2005;41:35-41
9. Brook I, Gober AE. Bacteriology of spontaneously draining acute otitis media in children before and after the introduction of pneumococcal vaccination. Pediatr Infect Dis J 2009;28(7):640-2
10. Howie VM, Ploussard JH. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate triple sulfonamide, and placebo in280 patients with acute otitis media under two and one-half years of age. Clin Pediatr (Phila) 1972;11:205-14
11. Kilpi T, Herva E, Kaijalainen T, et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001;20:654-62
12. Barkai G, Leibovitz E, Givon-Lavi N, et al. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrentacute otitis media. Pediatr Infect Dis J 2009;28:466-71
13. Veenhoven R, Bogaert D, Uiterwaal RH, et al. Effect of conjugate pneumococcal vaccine followed by polysacharide pneumococcal vaccine on recurrent acute otitis media: a randomized study. Lancet 2003;361:2189-95
14. Dagan R, Schneider S, Givon-Lavi N, et al. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children. Pediatr Infect Dis J 2008;27:200-6
15. Howie VM, Owen MJ. Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media. Pediatr Infect Dis J 1987;6:989-91
16. Johnson CE, Carlin SA, Super DM, et al. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr 1991;119:117-22
17. Piglansky L, Leibovitz E, Raiz S, et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J 2003;22:405-12
18. Jacobs MR, Felmingham D, Appelbaum PC, et al., for the Alexander Project Group. The Alexander Project 1998-2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003;52:229-46
19. Drusano G, Craig W. Relevance of pharmacokinetics and pharmacodynamics in the selection for respiratory tract infections. J Chemother 1997;9:38-44
20. Arguedas A, Dagan R, Pichichero M, et al. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. Pediatr Infect Dis J 2006;25:211-8
21. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15:944-8
22. Jacobs MR, Bajksouzian S, Zilles A, et al. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U. S. Surveillance Study. Antimicrob Agents Chemother 1999;43:1901-8
23. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997;176:1253-9
24. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother 2000;44:43-50
25. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J 2000;19:1040-5
26. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Ped Infect Dis J 2001;20:260-4
27. Dagan R, Johnson C, McLinn S, et al. Bacteriological and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001;20:829-37
28. Dagan R, Johnson C, McLinn S, et al. Bacteriological and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000;19:95-104 (Pubitemid 30111402)
29. Hoberman A, Marchant CD, Kaplan SL. Kinetics and tolerability in children receiving 25mg/kg once daily. Pediatr Infect Dis J 2005;24:525-32
30. Marchant CD, Dagan R. Bacteriological efficacy of antimicrobial agents. In: Rosenfeld RM, Bluestone CD, editors. Evidence-based Otitis Media. 2nd edn. Hamilton, Ontario: 2003:256-67
31. Marchant CD, Carlin SA, Johnson CE, et al. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon". J Pediatr 1992;120:72-7
32. American Academy of Pediatrics and American Academy of Family Physicians. Diagnosis and management of AOM. Pediatrics 2004;113:1451-65